The first CTA identified was MAGE in melanoma, but subsequently BAGE, GAGE, SSX, LAGE-1, PRAME, and NY-ESO-1 have been identified as targets in sarcoma [23,24,25,26,27,28]. The gene discussed is SSX2; the disease is sarcoma.